-

Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers

Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dr. Jessica Shepherd is joining as the first Chief Medical Officer of Hers. As the company invests further in personalized healthcare designed for women, Dr. Shepherd will guide the clinical expertise that forms the foundation of the Hers brand across sexual health, dermatology, weight loss, and mental health.

Dr. Shepherd brings nearly twenty years of clinical experience in obstetrics, gynecology, and surgery to Hims & Hers. A board-certified OB/GYN, Dr. Shepherd has spent her career focused on areas of women’s health including endometriosis, fibroids, sexual health, menopausal health, and healthcare disparities for women. She is a leading voice in raising awareness of the importance of women's access to care that addresses their individual experiences at every life stage. She received her MD from Ross University School of Medicine and her MBA from University of Louisville. She was also previously the Director of Minimally Invasive Gynecologic Surgery at the University of Illinois at Chicago.

“When it comes to health and wellness, women are often unheard and unseen. There are clear issues in how women receive care and until we take care of the women who have the least amount of resources and access, we’ve got work to do. Hers is built to address those challenges head on,” said Dr. Jessica Shepherd. “Hers gives women agency in the healthcare decisions they make, so they can achieve better outcomes.”

Although the world has reached important milestones towards gender parity in recent years, there remains much to be done – especially concerning the women’s health gap. Women spend 25% more of their lives in poor health than men, according to a report from the World Economic Forum and the McKinsey Health Institute. Women’s health as a subject matter is chronically under-researched and neglected, even though women outnumber men in the US. 17% of women felt they were treated differently due to their sex when only 6% of men felt similarly. Hims & Hers seeks to bridge that gap by providing access to personalized care for women that is easy to access and affordable. Women can access care in categories across weight loss, sexual health, dermatology, and mental health, and Hers plans to expand in the coming years with access to treatment for more specific conditions associated with life stages like menopause and post-partum.

“Women’s health to us isn’t simply limited to reproductive health – it is inclusive of everything that makes a difference in how women feel about themselves and how they show up in their daily lives. As the Hers business continues to rapidly expand, we have the opportunity to help more women access the personalized care they deserve by elevating the standard of the status quo in women’s health and wellness,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “Dr. Shepherd brings the experience, expertise, and focus to Hers as we help more women find accessible, personalized care.”

Dr. Shepherd joins a team of medical leaders at Hims & Hers with more than 100 years of combined experience across weight loss, sexual health, mental health, and dermatology. These physicians are the clinical backbone of the company, providing critical medical expertise that informs the care available through Hims & Hers.

About Hims & Hers Health, Inc

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.com and www.forhers.com.

Contacts

Press Contact
Jinny Davoudi
press@forhims.com

Hims & Hers

NYSE:HIMS

Release Versions

Contacts

Press Contact
Jinny Davoudi
press@forhims.com

More News From Hims & Hers

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion of its weight loss specialty by enabling providers to prescribe a Compounded Semaglutide Pill with the same active ingredient as Wegovy®**. This needle-free treatment joins a full suite of weight loss solutions designed to meet the specific needs and preferences of individual customers. By leveraging nearly a decade of infrastructur...

Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care

SAN FRANCISCO--(BUSINESS WIRE)--Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by Galleri®, a simple cancer screening blood test that can detect a signal for 50+ types of cancer even before symptoms appear1. This multi-cancer early detection (MCED) test combines Hims & Hers’ scale with GRAIL’s innovative cancer screening technology to dramatically increase access to proactive care....

Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Monday, February 23, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international pa...
Back to Newsroom